17-07-2026 22:35 via drugs.com

More Weight Loss Reported With Dexamphetamine Versus Methylphenidate for ADHD

FRIDAY, July 17, 2026-- For children and adolescents with attention-deficit/hyperactivity disorder (ADHD), comparable, significant symptom improvement is seen with dexamphetamine and methylphenidate, but weight loss is greater with dexamphetamine...
Read more »

Pharmaceutical Industry news



2015 to 2023 Saw Decline in Health Care-Associated Infections in the U.S.
AAIC: Blood Test Detecting p-tau217 Levels Can Predict Progression to Cognitive Impairment
AAIC: Blood-Based Biomarkers for Alzheimer Disease Improve Accuracy of Diagnosis
Peptide Vaccine Targeting KRAS Mutations Promising for Pancreatic Ductal Adenocarcinoma
Seniors Undergoing High-Risk Emergency General Surgery Have Fewer Healthy Days at Home
Tobacco Treatment Program Effective in Oncology Settings
Odds of Stroke Lower Among Black Individuals Who Have Immigrated
New Cancer Cases Predicted to Increase to 34.4 Million by 2050
About One-Third of Women 35 Years and Older Report Perimenopause Uncertainty
Increase in Smoking Unlikely With Very Low Nicotine Cigarettes
High-Dose Intravenous Vitamin C May Benefit Trauma Patients
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
Global Findings Indicate Breast Cancer and A-Fib Incidence Frequently Overlap
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy
Desktop versie